How Growth Hormone Peptides Work in Women: Three Brain Pathways Activate the GH System
Continuous 24-hour GHRP-2 infusion in women activated the GH axis through three distinct mechanisms — pituitary, hypothalamic GHRH amplification, and somatostatin suppression — revealing complex neuroregulation.
Quick Facts
What This Study Found
GHRP-2 activates the female GH axis through three mechanisms: direct pituitary somatotroph stimulation, amplification of endogenous GHRH release, and functional somatostatin withdrawal, explaining its synergy with GHRH.
Key Numbers
How They Did This
Clinical trial in women using continuous 24-hour IV GHRP-2 infusion combined with GHRH co-administration and pharmacological somatostatin pathway blocking. GH profiles sampled every 10 minutes for deconvolution analysis.
Why This Research Matters
Understanding the tripartite mechanism explains why GH secretagogues are so effective and how they differ from GHRH alone. This knowledge is essential for optimizing GH secretagogue therapy in women, who have distinct GH dynamics.
The Bigger Picture
GH regulation differs between men and women. This detailed mechanistic study in women provides sex-specific understanding essential for developing personalized GH secretagogue therapy.
What This Study Doesn't Tell Us
Relatively invasive protocol (24-hour IV infusion with frequent blood sampling). Small sample size typical for such intensive studies. Acute infusion may not reflect chronic dosing dynamics.
Questions This Raises
- ?Does the tripartite mechanism also apply to oral GH secretagogues?
- ?Which mechanism is most important for sustained GH release?
- ?Do the three pathways respond differently in aging women?
Trust & Context
- Key Stat:
- 3 pathways GHRP-2 works through direct pituitary, GHRH amplification, and somatostatin suppression mechanisms simultaneously in women
- Evidence Grade:
- Moderate evidence from a detailed mechanistic clinical study with intensive hormonal profiling, limited by small sample size and acute design.
- Study Age:
- Published in 1999. The tripartite GHRP mechanism has been confirmed and extended to understanding ghrelin's central effects.
- Original Title:
- Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.
- Published In:
- The Journal of clinical endocrinology and metabolism, 84(6), 2140-50 (1999)
- Authors:
- Shah, N(4), Evans, W S(4), Bowers, C Y(21), Veldhuis, J D
- Database ID:
- RPEP-00556
Evidence Hierarchy
Frequently Asked Questions
How does GHRP-2 release growth hormone?
Through three simultaneous mechanisms: directly stimulating pituitary GH cells, amplifying the brain's natural GHRH signal, and reducing the braking signal (somatostatin). This triple action explains its powerful GH-releasing effect.
Is GH regulation different in women?
Yes, women have distinct GH secretion patterns (more continuous, less pulsatile than men). This study provides sex-specific data on how GH peptides work in women, important for tailoring therapy.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00556APA
Shah, N; Evans, W S; Bowers, C Y; Veldhuis, J D. (1999). Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.. The Journal of clinical endocrinology and metabolism, 84(6), 2140-50.
MLA
Shah, N, et al. "Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.." The Journal of clinical endocrinology and metabolism, 1999.
RethinkPeptides
RethinkPeptides Research Database. "Tripartite neuroendocrine activation of the human growth hor..." RPEP-00556. Retrieved from https://rethinkpeptides.com/research/shah-1999-tripartite-neuroendocrine-activation-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.